R J Fountaine
Affiliation: Pfizer Global Research and Development
- Clinical pharmacology of lasofoxifene in Japanese and white postmenopausal womenR J Fountaine
Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06341, USA
J Clin Pharmacol 46:693-9. 2006
- Acute passive cigarette smoke exposure and inhaled human insulin (Exubera) pharmacokineticsRobert Fountaine
Pfizer Global Research and Development, Groton, CT and Environmental Medicine Incorporated, Westwood, NJ, USA
Br J Clin Pharmacol 65:864-70. 2008..The rate of clearance of radioaerosols such as technetium-labelled diethylenetriamine penta-acetic acid is decreased in response to passive smoke exposure...
- Increased food intake and energy expenditure following administration of olanzapine to healthy menRobert J Fountaine
Pfizer Global Research and Development, New London, Connecticut, USA
Obesity (Silver Spring) 18:1646-51. 2010..This study provides evidence that OLZ pharmacology drives the early increase in weight through increased FI, without evidence of decreased energy expenditure (EE), activity level, or short-term perturbations in IS...